Search results
Results from the WOW.Com Content Network
Canine cognitive dysfunction (CCD) is a disease prevalent in dogs that exhibit symptoms of dementia or Alzheimer's disease shown in humans. [1] CCD creates pathological changes in the brain that slow the mental functioning of dogs resulting in loss of memory, motor function, and learned behaviors from training early in life.
The AKC reports that one study found that 28% of dogs between 11 and 12 years of age have at least one sign of dog dementia, and that increased to 68% in dogs over 15 years of age.
Atenolol is a beta blocker medication primarily used to treat high blood pressure and heart-associated chest pain. [7] Although used to treat high blood pressure, it does not seem to improve mortality in those with the condition. [8] [9] Other uses include the prevention of migraines and treatment of certain irregular heart beats.
POCD is common in adult patients of all ages at hospital discharge after major noncardiac surgery, but only the elderly (aged 60 years or older) are at significant risk for long-term cognitive problems. Patients with POCD are at an increased risk of death in the first year after surgery. [9]
For premium support please call: 800-290-4726 more ways to reach us
Animal-assisted therapy is an alternative or complementary type of therapy that includes the use of animals in a treatment. [4] [5] It falls under the realm of animal-assisted intervention, which encompasses any intervention in the studio that includes an animal in a therapeutic context such as emotional support animals, service animals trained to assist with daily activities, and animal ...
The hallmark symptom of LATE is a progressive memory loss that predominantly affects short-term and episodic memory. [1] This impairment is often severe enough to interfere with daily functioning and usually remains the chief neurologic deficit, unlike other types of dementia in which non-memory cognitive domains and behavioral changes might be noted earlier or more prominently. [1]
The study, published in the Lancet's eClinicalMedicine journal on Thursday, explored more than 100 million medical records of U.S. patients to see if Ozempic increased the risk of several ...